BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mori A, Cross B, Uchida S, Kerrick Walker J, Ristuccia R. How Are Adenosine and Adenosine A2A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis? Biomedicines 2021;9:1027. [PMID: 34440231 DOI: 10.3390/biomedicines9081027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Martinez-Gonzalez L, Martinez A. Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert Opin Investig Drugs 2023;32:141-60. [PMID: 36762798 DOI: 10.1080/13543784.2023.2178416] [Reference Citation Analysis]
2 Bassani D, Pavan M, Federico S, Spalluto G, Sturlese M, Moro S. The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? Int J Mol Sci 2022;23:4504. [PMID: 35562894 DOI: 10.3390/ijms23094504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mori A, Chen JF, Uchida S, Durlach C, King SM, Jenner P. The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease. Molecules 2022;27:2366. [PMID: 35408767 DOI: 10.3390/molecules27072366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Poorjam M, mohammadi Z, Jafari SM, Metabolic disorder research center, Golestan University if Medical Sciences, Gorgan, Iran/Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran, Metabolic disorder research center, Golestan University if Medical Sciences, Gorgan, Iran/Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Metabolic disorder research center, Golestan University if Medical Sciences, Gorgan, Iran/Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran sciences. Adenosine Receptor Signaling in Diseases with Focus on Cancer. Jorjani Biomed J 2022;10:41-55. [DOI: 10.52547/jorjanibiomedj.10.1.41] [Reference Citation Analysis]